Drug molecules transformed into nanoparticles or endowed with nanostructures with or
without the aid of carrier materials are referred to as “nanomedicines” and can overcome …

Polymer nanomedicines (macromolecular therapeutics, polymer-drug conjugates, drug-free
macromolecular therapeutics) are a group of biologically active compounds that are …

With the advancement of polymer engineering, complex star‐shaped polymer architectures
can be synthesized with ease, bringing about a host of unique properties and applications …

In the past several decades, nanosized drug delivery systems with various targeting
functions and controlled drug release capabilities inside targeted tissues or cells have been …

Introduction: Prodrugs have been used to improve the selectivity and efficacy of cancer
therapy by targeting unique abnormal markers that are overexpressed by cancer cells and …

It is almost four decades since N-(2-hydroxypropyl) methacrylamide (HPMA)-based
copolymers arose as drug carriers. Although fundamentals have been established and …

Incorporating labile bonds in chemical structure of polymer yields interesting materials that
are responsive to change of environmental stimuli such as change of pH values. Active …

The main objective of this review is to describe the importance of dendrimer prodrugs in the
design of new drugs, presenting numerous applications of these nanocomposites in the …

Abstract N-(2-hydroxypropyl) methacrylamide-based block copolymers (pHPMA) have
received attention due to their hydrophilicity, non-immunogenicity, biocompatibility and …

Targeted drug delivery using nano-sized carrier systems with targeting functions to
malignant and inflammatory tissue and tailored controlled drug release inside targeted …